Literature DB >> 6760958

Production of a tumor-specific xenoantiserum from partially purified immunoprotective tumor antigen.

T Tanaka, H Yamagishi, N R Pellis, B D Kahan.   

Abstract

Rabbits immunized with the immunoprotective TSTA fraction partially purified by preparative isoelectric focusing of 3 M KCl extracts from a chemically induced murine sarcoma, MCA-F, produced specific xenoantisera as assessed by an indirect membrane immunofluorescence assay. Only the immunizing tumor, MCA-F, and not the antigenically distinct MCA-D or MCA-T target cells were stained by the xenoantiserum. Absorption of anti-MCA-F antiserum with the antigenically distinct MCA-D or MCA-T cells did not reduce its capacity to bind to MCA-F cells. The immunofluorescence reaction was competitively inhibited by MCA-F fractions that induced specific immunoprotection: crude 3 M KCl extract, isoelectrically focused TSTA (fraction 15), and intact irradiated MCA-F cells. The TSTA specificity of these xenoantisera suggests that they may provide useful reagents for rapid isolation and characterization of the immunoprotective moiety.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6760958     DOI: 10.1007/bf00200200

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  19 in total

1.  Biologic and chemical characterization of HLA antigens in human serum.

Authors:  J P Allison; M A Pellegrino; S Ferrone; G N Callahan; R A Reisfeld
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

2.  Isoelectric focusing in layers of granulated gels. II. Preparative isoelectric focusing.

Authors:  B J Radola
Journal:  Biochim Biophys Acta       Date:  1975-03-28

3.  Multiple foreign non-H-2 determinants on the surface of a chemically-induced murine sarcoma.

Authors:  G Invernizzi; G Carbone; A Meschini; G Parmiani
Journal:  J Immunogenet       Date:  1977-04

4.  Restriction of CEA synthesis to the stationary phase of growth of cultured human colon carcinoma cells.

Authors:  B Drewinko; L Y Yand
Journal:  Exp Cell Res       Date:  1976-09       Impact factor: 3.905

5.  Immunochemical evidence of a tumor-specific surface antigen obtained by detergent solubilization of the membranes of a chemically induced sarcoma, meth-A.

Authors:  T Natori; L W Law; E Appella
Journal:  Cancer Res       Date:  1978-02       Impact factor: 12.701

6.  Tumor-protective and -facilitating antigens from 3 M KCl-solubilized tumor extracts.

Authors:  H Yamagishi; N R Pellis; B D Kahan
Journal:  J Surg Res       Date:  1979-04       Impact factor: 2.192

Review 7.  Tumor-bound immunoglobulins: in situ expressions of humoral immunity.

Authors:  I P Witz
Journal:  Adv Cancer Res       Date:  1977       Impact factor: 6.242

8.  Biological and chemical characterization of human histocompatibility antigens.

Authors:  R A Reisfeld; B D Kahan
Journal:  Fed Proc       Date:  1970 Nov-Dec

9.  Specific tumor immunity induced with soluble materials: restricted range of antigen dose and of challenge tumor load for immunoprotection.

Authors:  N R Pellis; B D Kahan
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

10.  Tumour antigens and alloantigens. II. Lack of association of rat hepatoma-D23-specific antigen with beta 2 microglobulin.

Authors:  J G Bowen; R W Baldwin
Journal:  Int J Cancer       Date:  1979-06-15       Impact factor: 7.396

View more
  3 in total

1.  Purification of immunoprotective tumor antigens by preparative isotachophoresis.

Authors:  T L Saunders; B D Kahan; N R Pellis
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

Review 2.  Noncytolytic extraction of cell surface antigens using butanol.

Authors:  S J LeGrue
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

3.  Carrier and adjuvant properties of liposome-borne tumor-specific antigens.

Authors:  S J LeGrue
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.